Urinary manifestations of genitourinary syndrome of menopause: a review of the pathophysiology, clinical presentation, and management. [PDF]
Gynecol Pelvic MedSaad JC, Brandon CA.
europepmc +1 more source
Vaginal dilator therapy for pelvic cancer patients: a review. [PDF]
Gynecol Oncol RepNair N +4 more
europepmc +1 more source
Intravaginal Formulation Strategies for Vaginal Disorders: Optimizing Phytochemical and Biological Preparations-A Review. [PDF]
MoleculesHwang JH, Nam EY.
europepmc +1 more source
Intraoperative complications during gender-affirming laparoscopic hysterectomy in transgender men receiving testosterone: a case series. [PDF]
BMC SurgRokhgireh S +5 more
europepmc +1 more source
Related searches:
Recommendations for the management of postmenopausal vaginal atrophy
Climacteric, 2010Unlike hot flushes and night sweats which resolve spontaneously in time, atrophic symptoms affecting the vagina and lower urinary tract are often progressive and frequently require treatment. The prevalence of vaginal dryness increases as a woman advances through the postmenopausal years, causing itching, burning and dyspareunia, and sexual activity is
Nick Panay, D W Sturdee
exaly +4 more sources
Assessment of vaginal atrophy: a review
International Urogynecology Journal, 2014 The aim of this study is to provide an evidence-based definition of vaginal atrophy (VA) and present an overview of subjective and objective measurements of VA applicable in clinical practice and research.A systematic literature search was performed in MEDLINE and EMBASE to identify studies reporting on measurement properties of diagnostic instruments ...
M A, Weber, J, Limpens, J P W R, Roovers
openaire +3 more sources
Pharmacotherapy for the treatment of vaginal atrophy
Expert Opinion on Pharmacotherapy, 2019 Despite its frequency, recognition and therapy of vulvovaginal atrophy (VVA) remain suboptimal. Wet mount microscopy, or vaginal pH as a proxy, allows VVA diagnosis in menopause, but also in young contraception users, after breast cancer, or postpartum. Intravaginal low dose estrogen product is the main therapy.
Gilbert G. G. Donders +3 more
openaire +4 more sources
An alternative approach for the treatment of vaginal atrophy.
Minerva ginecologica, 2014 The aim of this study was to determine the efficacy of a new topic non-hormonal treatment for postmenopausal women complaining of symptoms of vaginal atrophy.Patients included in the study were prescribed Sinecol gel (AM PHARMA Srl, Vimercate, Monza and Brianza, Italy) application once a day for 20 consecutive days.
Quaranta L +8 more
openaire +4 more sources
Management of Vaginal Atrophy: Implications from the REVIVE Survey
Clinical Medicine Insights Reproductive Health, 2014 Vulvar and vaginal atrophy (VVA) is a chronic and progressive medical condition common in postmenopausal women. Symptoms of VVA such as dyspareunia, vaginal dryness, irritation, and itching can negatively impact sexual function and quality of life.
Sheryl A Kingsberg, Michael Krychman
exaly +2 more sources